Ca 153

Ca 153. The concentration of CA 153 tends to increase as the cancer grows In metastatic breast cancer the highest concentrations of CA 153 are often seen when the cancer has spread to the bones and/or the liver A negative CA 153 result cannot be used to confirm the absence of breast cancer in a patient In addition 25% to 30% of individuals with advanced breast cancer have tumours.

CA 153 is sensitive to proteases and neuraminidases and hence it is important to prepare and store samples with great care to avoid microbial contamination • Levels of CA 153 can also be elevated due to lung and ovarian cancers • Elevated values are seen in less than 10% of benign diseases of liver breast ovary GI tract and lung •.

Normal CA 153 (Carcinoma Antigen) in a blood test

The CA 153 (carcinoma antigen) is a tumor marker It means that it raises in the presence of a malignant tumor Tumor markers are used in the followup of treatment for some types of cancer The CA 153 along with the CA 2729 and the CEA markers is used in the followup of treated breast cancer.

Cancer Antigen 153 Test: Uses, Procedure, Results

PDF filePPTC 153 (102021) 6 PERIOD OF VALIDITY (SEE INSTRUCTIONS SECTION C) Choose one (1) of the following periods of validity 5year or 10year 7 ADDITIONAL PERSONAL INFORMATION Note If insufficient space include form PPTC 056 Additional Information – Address and Occupation available on Canadaca/passport A Addresses in the last two (2.

CA153 Exeter Clinical Laboratory International

The CA 153 marker is most useful in evaluating the effect of treatment for women with advanced breast cancer Elevated levels of CA 153 are also associated with cancers of the ovary lung and prostate as well as noncancerous conditions such as benign breast or ovarian disease endometriosis pelvic inflammatory disease and hepatitis.